Structure | Chemical Name | CAS | MF |
|
8-ETHYL-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID
|
170648-67-6
|
C12H11NO3
|
|
1H-Benzimidazole-2-methanol,4-nitro-(9CI)
|
170648-89-2
|
C8H7N3O3
|
|
Phenol, 3-(1-propynyl)- (9CI)
|
170651-14-6
|
C9H8O
|
|
Phenol, 4-(1-propynyl)- (9CI)
|
170651-15-7
|
C9H8O
|
|
6-methylaceanthrylene
|
170653-86-8
|
C17H12
|
|
Piperazine, 3-(1,1-dimethylethyl)-1-methyl- (9CI)
|
170654-21-4
|
C9H20N2
|
|
Ethanone, 2,2-difluoro-1-(5-methyl-2-furanyl)-2-(methylthio)- (9CI)
|
170654-37-2
|
C8H8F2O2S
|
|
Ethanone, 1-cyclohexyl-2,2-difluoro-2-(methylthio)- (9CI)
|
170654-39-4
|
C9H14F2OS
|
|
2-chloro-N-(2,2,2-trifluoroethyl)acetamide
|
170655-44-4
|
C4H5ClF3NO
|
|
2-CHLORO-N-(4-MORPHOLIN-4-YL-PHENYL)-ACETAMIDE
|
170655-46-6
|
C12H15ClN2O2
|
|
H-LEU-GLN-VAL-GLN-LEU-SER-ILE-ARG-OH
|
170655-69-3
|
C42H77N13O12
|
|
Carbamic acid, [4-(cyanoamino)butyl]-, 1,1-dimethylethyl ester (9CI)
|
170655-82-0
|
C10H19N3O2
|
|
(2E)-N-(4-bromophenyl)-2-(3,3-dimethyl-2,4-dihydroisoquinolin-1-yliden e)acetamide
|
170658-12-5
|
C19H19BrN2O
|
|
2-(3,4-Dihydro-3,3-dimethyl-1(2H)-isoquinolinylidene)-N-(2,4,6-trimeth ylphenyl)acetamide
|
170658-20-5
|
C22H26N2O
|
|
Acetamide, 2-(3,4-dihydro-3,3-dimethyl-1(2H)-isoquinolinylidene)-N-(2- methylphenyl)-
|
170658-21-6
|
C20H22N2O
|
|
Thiazolo[3,2-b][1,2,4]triazole, 6-(chloromethyl)- (9CI)
|
170658-31-8
|
C5H4ClN3S
|
|
3-(Benzylaminomthyl)thiazolo(3,2-a)benzimidazole dihydrochloride
|
170658-33-0
|
|
|
2-[(4-phenylpiperazin-1-yl)methyl]-4-thia-1,6,8-triazabicyclo[3.3.0]oc ta-2,5,7-triene hydrochloride
|
170658-35-2
|
C15H18ClN5S
|
|
2-(imidazol-1-ylmethyl)-4-thia-1,6,8-triazabicyclo[3.3.0]octa-2,5,7-tr iene hydrochloride
|
170658-36-3
|
C8H8ClN5S
|
|
1H-Indol-1-yl,5-bromo-3-(carboxymethyl)-(9CI)
|
170660-53-4
|
C10H7BrNO2*
|
|
1H-Indol-1-yl,3-(carboxymethyl)-5-hydroxy-(9CI)
|
170660-54-5
|
C10H8NO3*
|
|
1H-Indol-1-yl,3-(carboxymethyl)-5-methoxy-(9CI)
|
170660-55-6
|
C11H10NO3*
|
|
1H-Indol-1-yl,3-(carboxymethyl)-2-methyl-(9CI)
|
170660-56-7
|
C11H10NO2*
|
|
5-chloro-1-methyl-3-nitropyridin-2(1H)-one
|
170661-48-0
|
C6H5ClN2O3
|
|
ALPHA-CONOTOXIN EL
|
170663-33-9
|
C83H125N27O27S5
|
|
3-METHYL-1-BUTYL-D11 ALCOHOL
|
170678-50-9
|
C5HD11O
|
|
5-BROMO-7-METHYLBENZOFURAN
|
170681-91-1
|
C9H7BrO
|
|
1-METHYL-5-TRIBUTYLSTANNANYL-1H-[1,2,3]TRIAZOLE
|
170681-98-8
|
C15H31N3Sn
|
|
3-NITRO-4-(4'-FLUOROPHENYL) PYRIDINE
|
170682-38-9
|
C11H7FN2O2
|
|
5-Benzofuranamine,7-methyl-(9CI)
|
170682-46-9
|
C9H9NO
|
|
(1-Methyl-1H-pyrazol-5-yl)tributylstannane
|
170682-50-5
|
C16H32N2Sn
|
|
N-[5-[2-[Bis[4-(difluoroMethoxy)phenyl]MethylaMino]-1(R)-hydroxyethyl]-2-hydroxyphenyl]MethanesulfonaMide
|
170686-12-1
|
C24H24F4N2O6S
|
|
(R)-N-(2-(benzyloxy)-5-(2-broMo-1-hydroxyethyl)phenyl)MethanesulfonaMide
|
170687-82-8
|
C16H18BrNO4S
|
|
1H-Pyrrole-2-carbonylfluoride,1-methyl-5-(trifluoromethyl)-(9CI)
|
170693-22-8
|
C7H5F4NO
|
|
1,4-Benzenediamine,N-cyclopropyl-(9CI)
|
170693-31-9
|
C9H12N2
|
|
1,4-Benzenediamine, N4-cyclopropyl-2-methyl-
|
170693-34-2
|
C10H14N2
|
|
5-(4-FLUOROPHENYL) ISOTHIAZOLE
|
170696-25-0
|
C9H6FNS
|
|
4-(chlorosulfonyl)phthalonitrile
|
170697-25-3
|
C8H3ClN2O2S
|
|
Quinoline, 4-ethoxy-1,2,3,4-tetrahydro-2,7-dimethyl- (9CI)
|
170697-86-6
|
C13H19NO
|
|
Quinoline, 4-ethoxy-1,2,3,4-tetrahydro-2,6-dimethyl- (9CI)
|
170697-87-7
|
C13H19NO
|
|
Hexa-dodecyl-hexa-peri-hexabenzocoronene
|
170698-88-1
|
C114H162
|
|
4-Iodododecyl benzene
|
170698-90-5
|
C18H29I
|
|
METHYL 2-ACETAMIDO-3-(3,4-DIACETOXYPHENYL)-2-PROPENOATE
|
170699-07-7
|
C16H17NO7
|
|
1,4-Bis(phenylmethyl)-2-piperazinecarbonitrile
|
170701-81-2
|
C19H21N3
|
|
AZIRIDINE-1,2-DICARBOXYLIC ACID 1-BENZYL ESTER 2-METHYL ESTER
|
170701-87-8
|
C12H13NO4
|
|
4-BENZYL-3-CYANOMETHYLMORPHOLINE
|
170701-93-6
|
C13H16N2O
|
|
(1-benzylpiperidin-2-yl)methanamine
|
170701-98-1
|
C13H20N2
|
|
4-benzyl-1,4-oxazepan-6-aMine
|
170701-99-2
|
C12H18N2O
|
|
5,5'-DibroMo-3,3'-dihexyl-2,2'-bithiophene
|
170702-05-3
|
C20H28Br2S2
|
|
(1S,2S)-N,N'-DI-P-TOLUENESULFONYL-1,2-DIPHENYL-1,2-ETHYLENEDIAMINE
|
170709-41-8
|
C28H28N2O4S2
|
|
6beta-Hydroxyhispanone
|
170711-93-0
|
C20H28O3
|
|
3-(1-Methylethyl)-6-(phenylMethyl)-2(1H)-pyrazinone
|
170713-71-0
|
C14H16N2O
|
|
NOCICEPTIN
|
170713-75-4
|
C79H129N27O22
|
|
[4aS-[4aα,6α,8aα,8bβ,10aα,11α(1S*,2E,4R*),13aβ,13bα]]-5,6,7,8,8a,8b,10,10a,11,12,13,13a-Dodecahydro-6-hydroxy-8a,10a-diMethyl-2-phenyl-11-[1,4,5-triMethyl-5-[(tetrahydro-2H-pyran-2-yl)oxy]-2-hexenyl]-4a,13b-etheno-1H,9H-benzo[c]cyclopenta[h][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione
|
170716-87-7
|
C41H57N3O5
|
|
Benzamide, 3-fluoro-4-methyl- (9CI)
|
170726-98-4
|
C8H8FNO
|
|
3-Pyridinecarbonitrile,6-[(hydroxyimino)methyl]-(9CI)
|
170727-00-1
|
C7H5N3O
|
|
3-Bromothiophene-2-sulphonyl chloride
|
170727-02-3
|
C4H2BrClO2S2
|
|
Loratadine EP Impurity E
|
170727-59-0
|
C22H23ClN2O2
|
|
7,8-dihydro-1H-furo[2,3-g]indole
|
170728-95-7
|
C10H9NO
|
|
2H-1-Benzopyran-5-amine(9CI)
|
170729-16-5
|
C9H9NO
|
|
Defluoro Aprepitant
|
170729-76-7
|
C23H22F6N4O3
|
|
[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine
|
170729-79-0
|
C20H18F7NO2
|
|
Aprepitant
|
170729-80-3
|
C23H21F7N4O3
|
|
7-Acetyl-2,3-dihydrobenzofuran
|
170730-06-0
|
C10H10O2
|
|
Cyclopropanecarbonitrile, 1-(3-pyridinyl)- (9CI)
|
170734-10-8
|
C9H8N2
|
|
3-CHLORO-4-METHYL-BENZAMIDINE
|
170735-25-8
|
C8H9ClN2
|
|
2-(3-CHLORO-PHENOXY)ACETAMIDINE
|
170735-26-9
|
C8H9ClN2O
|
|
Benzyl4-forMylcyclohexylcarbaMate
|
170737-41-4
|
C15H19NO3
|
|
6-bromonaphthalene-2-carbaldehyde
|
170737-46-9
|
C11H7BrO
|
|
1-N-Cbz-4-Methoxycarbonylmethyl-piperidine
|
170737-53-8
|
C16H21NO4
|
|
4-Chloro-2-Methoxybenzyl cyanide
|
170737-92-5
|
C9H8ClNO
|
|
(2-CHLORO-4-METHOXYPHENYL)ACETONITRILE
|
170737-93-6
|
C9H8ClNO
|
|
2-Methoxy-4-chlorophenylacetic acid
|
170737-95-8
|
C9H9ClO3
|
|
Hydroxyethyl Beta-Cyclodextrin
|
170744-18-0
|
C69H117NO44
|
|
O,O'-BIS(4-TERT-BUTYLBENZOYL)-N,N'-DIALLYL-L-TARTARDIAMIDE
|
170744-22-6
|
C32H40N2O6
|
|
7-Benzothiazolamine,2-chloro-6-methyl-(9CI)
|
170745-97-8
|
C8H7ClN2S
|
|
4,7-Benzothiazoledione,2-chloro-6-methyl-(9CI)
|
170745-98-9
|
C8H4ClNO2S
|
|
1H-Pyrrole-1-carboxamide,2,5-dihydro-N-hydroxy-2,5-dimethyl-,(2S-trans)-(9CI)
|
170747-75-8
|
C7H12N2O2
|
|
Carbamic acid, (6-oxo-2,4-hexadienyl)-, 1,1-dimethylethyl ester, (E,E)- (9CI)
|
170748-20-6
|
C11H17NO3
|
|
3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester acetate
|
170749-59-4
|
C21H25N3O4
|
|
22CHLORO46DINITROPHENYLAZO5ETHYLAMINO4METHOXYACETANILIDE
|
170778-70-8
|
C17H17ClN6O6
|
|
Hexanedioic acid, polymer with 1,4-cyclohexanedimethanol and oxiranylmethyl 2-methyl-2-propenoate
|
170778-72-0
|
C21H36O9
|
|
2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-ethylhexyl 2-propenoate and ethyl 2-propenoate
|
170778-73-1
|
C24H42O6
|
|
HANATOXIN-1
|
170780-00-4
|
C181H264N48O51S6
|
|
HANATOXIN-2
|
170780-01-5
|
|
|
5'-Guanylic acid, 2'-deoxy-2'-fluoro-
|
170784-58-4
|
C10H13FN5O7P
|
|
Benzoic acid, 6-amino-2-ethyl-3-nitro- (9CI)
|
170785-03-2
|
C9H10N2O4
|
|
2(1H)-Pyrimidinethione,3,4-dihydro-1-(1-methylethyl)-(9CI)
|
170787-12-9
|
C7H12N2S
|
|
Efaproxiral sodium
|
170787-99-2
|
C20H24NNaO4
|
|
1H-Pyrazole-5-carbonyl chloride, 4-chloro-3-methoxy-1-methyl- (9CI)
|
170788-56-4
|
C6H6Cl2N2O2
|
|
TritylCandesartanCilexetil,CandesartanCilexetil
|
170791-07-0
|
|
|
Trityl candesartan cilexetil
|
170791-09-0
|
C52H48N6O6
|
|
4-CHLORO-3-FLUOROPHENYLMAGNESIUM BROMIDE
|
170793-00-7
|
C6H3BrClFMg
|
|
Des-5’-chloro-4-fluorobenzyl Mosapride
|
170799-30-1
|
C14H21N3O3
|
|
N,N-Diacetyl Des-5’-chloro-4-fluorobenzyl Mosapride
|
170799-31-2
|
C18H25N3O5
|
|
N,N-Diacetyl Des-4-fluorobenzyl Mosapride
|
170799-32-3
|
C18H24ClN3O5
|
|
2-(3-(dibenzylamino)-2-hydroxypropyl)isoindoline-1,3-dione
|
170799-33-4
|
C25H24N2O3
|
|
6-(AMinoMethyl)Morpholin-3-one hydrochloride
|
170799-36-7
|
C5H11ClN2O2
|
|
Benzene, (4-ethoxycyclohexyl)-, trans- (9CI)
|
170800-47-2
|
C14H20O
|
|
Benzene, (4-ethoxycyclohexyl)-, cis- (9CI)
|
170800-48-3
|
C14H20O
|